Navigation Links
YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
Date:11/11/2010

4
203,498,239   Share purchase warrants
,473,24
,473,246   Contributed surplus
4,679,924
4,088,671   Deficit
(174,862,730)
(167,245,315) 44,812,88
51,814,841 Basis of presentation Commitments $ 51,107,077 $ 57,774,767 YM BIOSCIENCES INC.
Interim Consolidated Statements of Operations and Comprehensive Loss and Deficit
(Expressed in Canadian dollars, unless otherwise noted) Three months ended September 30, 2
2009 (Unaudited) Out-licensing revenue
$ 342,356 $ 727,538 Interest income
55,635
9,119 397,99
746,657 Expenses:   Licensing and product development
5,209,18
2,436,048   General and administrative
2,417,
,784,432 7,626,287
4,220,480 Loss before the undernoted
(7,228,296)
(3,473,823) Loss on foreign exchange
(406,834)
(26,747) Gain (loss) on short-term deposits
,97
(2,218) Gain on disposal of property and equipment
,744
- Loss and comprehensive loss for the period
(7,617,415)
(3,502,788) Deficit, beginning of period
(167,245,315)
(146,251,951) Deficit, end of period
$
(174,862,730) $
(149,754,739) Basic and diluted loss per common share
$
(0.09) $
(0.06) Weighted average number of common
shares outstanding80,382,
55,844,505

YM BIOSCIENCES INC.
Interim Consolidated Statements of Cash Flows
(Expressed in Canadian dollars, unless otherwise noted)   Three months ended September 30, 2010 2009 (Unaudited) Cash provided by (used in): Operating activities:   Loss for the period $ (7,617,415) $
(3,502,788)   Items not involving cash:Amortization of property and equipment
9,358
,252
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. YM BIOSCIENCES REPORTS SIGNIFICANT RESPONSE RATES IN ANEMIA, SPLENOMEGALY, AND CONSTITUTIONAL SYMPTOMS FROM THE PHASE I/II TRIAL OF ITS JAK1/JAK2 INHIBITOR, CYT387, IN MYELOFIBROSIS
2. Regado Biosciences Awarded Three Grants from the Federal Government to Advance Research of Lead Programs
3. Sangamo BioSciences Awarded Grants for the Development of Four ZFP Therapeutic® Programs
4. Ardea Biosciences Awarded a $733,438 Grant from the U.S. Government Under the Patient Protection and Affordable Care Act
5. X-BODY BioSciences Awarded Grant for Therapeutic Discovery Project Targeting Metastatic Tumor Stem Cells
6. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
7. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
8. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
9. Sangamo BioSciences Announces Third Quarter 2010 Conference Call and Webcast
10. Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2010 Financial Results
11. Cell Biosciences to Acquire Convergent Bioscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... researchers led by Northeastern University has developed a ... and a variety of nanocarbon structures in carbon ... scalable, which will allow the researchers to tailor ... in applications ranging from electronic devices to CNT-reinforced ... sports equipment. , Their findings were published in ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 Research ... "Whole Exome Sequencing Market by Product, by Services, by Technology, ... their offering. Whole Exome Sequencing (WES) is ... the genome, i.e. the exon. The exome, which is the ... of the total genome and is actually converted into proteins ...
(Date:9/15/2014)... , 15 septembre 2014 La ... Week (IPAW) (semaine internationale sur la sensibilisation ... octobre. Initiative conjointe de la Plasma Protein ... sociétés membres , l,IPAW vise à : ... sujet de la collecte du plasma-aphérèse , ...
(Date:9/14/2014)... 2014 UMBC’s Biotechnology Graduate Programs’ ... October 21, 2014, from 12:00 to 1:00 p.m. EDT. ... innovative curriculum and practice-oriented instruction, designed for working professionals. ... help advance their career in the biotechnology industry. , ... , About UMBC’s Biotechnology Graduate Programs, UMBC offers ...
Breaking Biology Technology:Northeastern University Researchers Develop Novel Method for Working with Nanotubes 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 2Global Whole Exome Sequencing (Systems, Kits, Library Preparation, Target Enrichment) Market by Product, by Services, by Technology, by Application - Forecast to 2018 3L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... INDIANAPOLIS, and SAN DIEGO, July 8 Eli Lilly,and ... (Nasdaq: SGXP ) today,announced that the companies have ... SGX in an all-cash transaction. SGX, based,in San Diego, ... development in the area of oncology. Under the terms ...
... in diagnostics, imaging, and ... ... Institute, and Case Western Reserve University today,announced the organizations will partner ... diagnostics, imaging and therapeutics,to improve medical treatment and patient care., ...
... July 8 Royalty Pharma is pleased to announce,that ... Vice,President, Head of Research. Dr. Reddoch has 17 years ... last 12 years as an equity analyst,most recently as ... Markets. He previously worked at Banc of America,Securities, and ...
Cached Biology Technology:Lilly to Acquire SGX Pharmaceuticals 2Lilly to Acquire SGX Pharmaceuticals 3Lilly to Acquire SGX Pharmaceuticals 4Lilly to Acquire SGX Pharmaceuticals 5NanoMedicine Summit Returns to Cleveland, September 25-26 2NanoMedicine Summit Returns to Cleveland, September 25-26 3NanoMedicine Summit Returns to Cleveland, September 25-26 4Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team 2
(Date:9/15/2014)... GEOMAR Helmholtz Centre for Ocean Research Kiel and ... for the first time, that the single most ... Emiliania huxleyi , can adapt simultaneously to ocean ... the researchers found no evidence for the widespread ... of climate change would interfere with each other. ...
(Date:9/15/2014)... 100 feet long and weighing as much as 170 tons, ... and by far the heaviest living thing ever seen on ... common with the tiniest fish larvae, which measure millimeters in ... gram, right? , Not so fast, says L. Mahadevan, ... Organismic and Evolutionary Biology, and of Physics. , Using ...
(Date:9/15/2014)... , , , ... , , , , ... set of symptoms. The finding could be a first... , , ... , , , , , ... , , , , , , , New research shows that schizophrenia isn,t ...
Breaking Biology News(10 mins):Small algae with great potential 2Small algae with great potential 3The science behind swimming 2The science behind swimming 3Schizophrenia not a single disease but multiple genetically distinct disorders 2Schizophrenia not a single disease but multiple genetically distinct disorders 3Schizophrenia not a single disease but multiple genetically distinct disorders 4Schizophrenia not a single disease but multiple genetically distinct disorders 5
... can affect healthy people,s personality traits as well as ... reveals a thesis from the University of Gothenburg, Sweden. ... is responsible for defending humans against infection as well ... vital for our survival. Research has demonstrated that inflammatory ...
... for the French National Institute for Agricultural Research INRA ... Apidologie , Annals of Forest Sciences , ... Sustainable Development and Veterinary Research (all ... published by the prestigious institute have gained an excellent ...
... the lower the risk of developing low- and high-grade ... Biomarkers & Prevention , a journal of the American ... of Illinois at Chicago, used self-reported data on medically ... glioma and 612 cancer-free patients from Duke University and ...
Cached Biology News:Genes of the immune system are associated with increased risk of mental illness 2Springer and the French National Institute for Agricultural Research INRA team up 2Allergies lower risk of low- and high-grade glioma 2
...
... Monoclonal Anti-β-Tubulin IV Recognizes an ... sequence of β-tubulin isotype IV. ... isotypes is observed. ascites fluid ... C-terminal sequence of β-tubulin isotype ...
... Finnpipette BioControl is a major step ... complete liquid handling system - with ... tip cone modules. All five single ... modules fit one handle. The lightweight ...
... the joining of two strands of DNA ... of adjacent nucleotides in either a cohesive-ended ... also been shown to catalyze the joining ... RNA strand in a duplex molecule but ...
Biology Products: